The store will not work correctly when cookies are disabled.
3-(4-Nitro-phenylsulfanyl)-1,3-diphenylpropan-1-one
ID: ALA1819223
PubChem CID: 56672128
Max Phase: Preclinical
Molecular Formula: C21H17NO3S
Molecular Weight: 363.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CC(Sc1ccc([N+](=O)[O-])cc1)c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C21H17NO3S/c23-20(16-7-3-1-4-8-16)15-21(17-9-5-2-6-10-17)26-19-13-11-18(12-14-19)22(24)25/h1-14,21H,15H2
Standard InChI Key: MNEXHRFTJIQXRK-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
12.4777 -7.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4766 -7.9648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1914 -8.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9078 -7.9644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9050 -7.1338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1896 -6.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6230 -8.3757 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.3368 -7.9621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0519 -8.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3355 -7.1371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0493 -6.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0480 -5.8985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7644 -7.1349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0485 -9.1969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7628 -9.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4776 -9.1945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4736 -8.3653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7588 -7.9577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7629 -5.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7620 -4.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0463 -4.2535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3302 -4.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3346 -5.4944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7625 -6.7254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0481 -7.1381 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7623 -5.9004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11 13 2 0
1 2 2 0
9 14 2 0
4 7 1 0
14 15 1 0
3 4 2 0
15 16 2 0
7 8 1 0
16 17 1 0
17 18 2 0
18 9 1 0
8 9 1 0
12 19 2 0
4 5 1 0
19 20 1 0
8 10 1 0
20 21 2 0
2 3 1 0
21 22 1 0
10 11 1 0
22 23 2 0
23 12 1 0
5 6 2 0
11 12 1 0
6 1 1 0
24 25 2 0
24 26 1 0
1 24 1 0
M CHG 2 24 1 26 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.44 | Molecular Weight (Monoisotopic): 363.0929 | AlogP: 5.70 | #Rotatable Bonds: 7 |
Polar Surface Area: 60.21 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.59 | CX LogD: 5.59 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.23 | Np Likeness Score: -1.00 |
References
1. Kumar A, Tripathi VD, Kumar P, Gupta LP, Akanksha, Trivedi R, Bid H, Nayak VL, Siddiqui JA, Chakravarti B, Saxena R, Dwivedi A, Siddiquee MI, Siddiqui U, Konwar R, Chattopadhyay N.. (2011) Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents., 19 (18): [PMID:21871812] [10.1016/j.bmc.2011.07.056] |